Fong To

427 total citations
13 papers, 320 citations indexed

About

Fong To is a scholar working on Immunology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fong To has authored 13 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fong To's work include Atherosclerosis and Cardiovascular Diseases (10 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Fong To is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (10 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Fong To collaborates with scholars based in Sweden, Netherlands and Germany. Fong To's co-authors include Eva Bengtsson, Jan Nilsson, Pontus Dunér, Anders Grubb, Stefan Jovinge, Katarina Håkansson, Harry Björkbacka, Gunilla Nordin Fredrikson, Lena Brånén and Ragnar Alm and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Fong To

13 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fong To Sweden 10 143 69 63 55 50 13 320
Sumihiko Hagita Japan 8 105 0.7× 147 2.1× 94 1.5× 43 0.8× 72 1.4× 12 404
Earl H. Rudolph United States 6 86 0.6× 51 0.7× 137 2.2× 24 0.4× 31 0.6× 8 323
J. Egido Spain 7 89 0.6× 80 1.2× 22 0.3× 114 2.1× 64 1.3× 11 412
Rick van Gorp Netherlands 6 102 0.7× 174 2.5× 96 1.5× 44 0.8× 38 0.8× 8 362
Joon-Keun Park Germany 5 53 0.4× 156 2.3× 60 1.0× 54 1.0× 20 0.4× 6 346
Maziar Riazy Canada 9 99 0.7× 135 2.0× 16 0.3× 47 0.9× 37 0.7× 17 301
Ryo Kawakami Japan 9 62 0.4× 122 1.8× 75 1.2× 31 0.6× 27 0.5× 21 275
Yuexin Zhu China 10 144 1.0× 158 2.3× 15 0.2× 48 0.9× 21 0.4× 25 400
Raquel Roldán-Montero Spain 9 139 1.0× 117 1.7× 63 1.0× 12 0.2× 26 0.5× 13 388

Countries citing papers authored by Fong To

Since Specialization
Citations

This map shows the geographic impact of Fong To's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fong To with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fong To more than expected).

Fields of papers citing papers by Fong To

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fong To. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fong To. The network helps show where Fong To may publish in the future.

Co-authorship network of co-authors of Fong To

This figure shows the co-authorship network connecting the top 25 collaborators of Fong To. A scholar is included among the top collaborators of Fong To based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fong To. Fong To is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Depuydt, Marie A.C., Irena Ljungcrantz, Fong To, et al.. (2024). Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation. Cardiovascular Research. 120(6). 581–595. 7 indexed citations
2.
Singh, Pratibha, Isabel Gonçalves, Mihaela Nitulescu, et al.. (2021). Correction to: Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events. Cardiovascular Diabetology. 20(1). 61–61. 2 indexed citations
3.
Singh, Pratibha, Isabel Gonçalves, Mihaela Nitulescu, et al.. (2020). Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events. Cardiovascular Diabetology. 19(1). 214–214. 12 indexed citations
4.
Dunér, Pontus, Eva Bengtsson, Irena Ljungcrantz, et al.. (2018). Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice. Journal of Biological Chemistry. 293(18). 6791–6801. 13 indexed citations
5.
Dunér, Pontus, Isabel Gonçalves, Helena Grufman, et al.. (2015). Increased aldehyde-modification of collagen type IV in symptomatic plaques – A possible cause of endothelial dysfunction. Atherosclerosis. 240(1). 26–32. 15 indexed citations
6.
Dunér, Pontus, Eva Bengtsson, Ragnar Alm, et al.. (2015). IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice. PLoS ONE. 10(1). e0117255–e0117255. 45 indexed citations
7.
Zetterqvist, Anna V., Lisa M. Berglund, Eliana Garcia‐Vaz, et al.. (2013). Inhibition of Nuclear Factor of Activated T-Cells (NFAT) Suppresses Accelerated Atherosclerosis in Diabetic Mice. PLoS ONE. 8(6). e65020–e65020. 34 indexed citations
8.
Engelbertsen, Daniel, Fong To, Pontus Dunér, et al.. (2012). Increased Inflammation in Atherosclerotic Lesions of DiabeticAkita-LDLr−/−Mice Compared to NondiabeticLDLr−/−Mice. Experimental Diabetes Research. 2012. 1–12. 19 indexed citations
9.
Dunér, Pontus, Fong To, Karsten Beckmann, et al.. (2011). Immunization of apoE–/– mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis. Cardiovascular Research. 91(3). 528–536. 33 indexed citations
10.
Dunér, Pontus, Fong To, Katarina Berg, et al.. (2010). Immune responses against aldehyde-modified laminin accelerate atherosclerosis in Apoe−/− mice. Atherosclerosis. 212(2). 457–465. 24 indexed citations
11.
Gonçalves, Isabel, Mikko P.S. Ares, Jonatan Moses, et al.. (2008). Elastin- and Collagen-Rich Human Carotid Plaques Have Increased Levels of the Cysteine Protease Inhibitor Cystatin C. Journal of Vascular Research. 45(5). 395–401. 7 indexed citations
12.
Bengtsson, Eva, Fong To, Anders Grubb, et al.. (2005). Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice. Atherosclerosis. 180(1). 45–53. 30 indexed citations
13.
Bengtsson, Eva, Fong To, Katarina Håkansson, et al.. (2005). Lack of the Cysteine Protease Inhibitor Cystatin C Promotes Atherosclerosis in Apolipoprotein E–Deficient Mice. Arteriosclerosis Thrombosis and Vascular Biology. 25(10). 2151–2156. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026